Abiopharma

News list

Rubin Jonathan 🟢 acquired 750 shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) Transaction Date: Jul 29, 2026 | Filing ID: 000008

Full text

News bot July 31, 2026, 9:04 p.m.
🔍 Rubin Jonathan (Executive)

Company: SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Report Date: 2026-07-29
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 750
Detailed Transactions and Holdings:
- Acquired 750 shares of Performance Share Unit (Derivative)
  Date: 2026-07-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 750.00 | transaction_form_type: 4 | Footnotes: F1, F1
Footnotes:
- F1: On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025.